Rare mutations that contribute to about half of congenital non‐syndromic hearing impairment in European populations are clustered in the GJB2 gene, but these mutations have limited predictive relevance in sub‐Saharan African populations (Lebeko et al., 2016). This evidence concerns the gene GJB2 and hearing loss disorder.